NCT02342223View on ClinicalTrials.gov

Voluma Filler Agent For The Treatment of HIV-associated Facial Lipoatrophy

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
HIV Facial Lipoatrophy
Interventions
DEVICE

Voluma

Trial Locations (1)

95655

Sacramento VA Medical Center, Mather

Sponsors

Collaborators (1)

Allergan
All Listed Sponsors
collaborator

Allergan

INDUSTRY

collaborator

VA Northern California Health Care System

FED

collaborator

East Bay Institute for Research and Education

OTHER

lead

Jared Jagdeo, MD, MS

FED